1. Administration, J.F.D., 2022. Guideline for the Registration of Biosimilar Drugs in Jordan.
2. Agency, E.M., 2022. Scientific Guidelines on Biosimilar Medicinal Products.
3. Role of community pharmacists in medication management during COVID-19 lockdown;Akour;Pathogens and global health,2021
4. Interchangeability of biosimilars: what level of clinical evidence is needed to support the interchangeability designation in the United States?;Alvarez;BioDrugs: clinical immunotherapeutics, biopharmaceuticals and gene therapy,2020
5. Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians;Barbier;J. Pharm. Policy Pract.,2021